Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02593812 · ClinicalTrials.gov registry record · NA

The Impact of Standard Medical Care (Dopamine) and Practice on Postural Motor Learning in Parkinson's Disease

A NA study of Parkinson Disease, sponsored by University of Utah.

Completed
Registry status
NA
Development phase
27
Enrollment target
1
Study location

NCT02593812: Completed NA study of Parkinson Disease, sponsored by University of Utah.

NCT02593812 is a NA study of Parkinson Disease that has completed, run by University of Utah. The registered enrollment target is 27 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02593812, a NA study of Parkinson Disease, has completed, sponsored by University of Utah.

COMPLETED
Registry status
NA
Development phase
27 participants
Enrollment target
1
Study location

Study Summary

The study determines whether standard medical care (dopamine) affects learning and retention of a postural stepping task in people with Parkinson's disease (PD) and whether training on a postural stepping task generalises to performance on an untrained postural task. Half the participants will train on the stepping task after they have taken their first dose of dopamine for the day (i.e. "on" medication state) while the other half will train on the same stepping task before taking their first daily dose of dopamine (i.e. "off" medication state).

Primary Outcome

Response time of the random sequence within initial retention trial, adjusted for baseline (i.e. the first trial of acquisition on Day 3)

Conditions Studied

Interventions

  • BEHAVIORAL Stepping training

Study Locations (1)

Utah

  • University of Utah - Salt Lake City

Trial Details

FieldValue
Enrollment Target 27 participants
Start Date 2016-07
Est. Completion 2017-05-11
Phase NA
University of Utah

818 total trials

What the finished NCT02593812 record still lists

NCT02593812 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 27 participants, a relatively small participant target, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (99% lower).

The record links to 1 condition, with Parkinson Disease appearing as the primary indexed condition, and to 1 intervention - of which Stepping training is the first listed.

NCT02593812 reports a single indexed study location in Utah.

Frequently Asked Questions

What is clinical trial NCT02593812 about?

NCT02593812 is a clinical study titled "The Impact of Standard Medical Care (Dopamine) and Practice on Postural Motor Learning in Parkinson's Disease". The study determines whether standard medical care (dopamine) affects learning and retention of a postural stepping task in people with Parkinson's disease (PD) and whether training on a postural stepping task generalises to performance on an untrained postural task. Half the participants will train...

What is the current status of trial NCT02593812?

This trial is currently completed. It is a NA study. The enrollment target is 27 participants. The study started on 2016-07. Estimated completion is 2017-05-11.

What conditions does trial NCT02593812 study?

This clinical trial studies the following conditions: Parkinson Disease.

What interventions are being tested in trial NCT02593812?

The interventions under investigation include: Stepping training (BEHAVIORAL).

Who is sponsoring clinical trial NCT02593812?

This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02593812 being conducted?

This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Parkinson Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02593812's enrollment target sits among peer trials

27 221st of 297 higher than 76 of 297 other Parkinson Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Parkinson Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00912041 · 27 participants · NA

    BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia

  • NCT02847559 · 27 participants · Phase 2

    Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma

  • NCT03380195 · 27 participants · NA

    Effects of Watermelon Juice on Heart Rate Recovery and Post-exercise Muscle Soreness

  • NCT03384238 · 27 participants · Phase 1

    Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02593812, the US trial registry maintained by the National Library of Medicine. NCT02593812 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.